Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Christen

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Cancer Research|March 14, 2001
P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatinX Lin, K Ramamurthi, M Mishima, et al.
Cancer Research|April 1, 1993
Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cellsE F McClay, K D Albright, J A Jones, et al.
British Journal of Cancer|September 1, 1994
Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell linesE F McClay, K D Albright, J A Jones, et al.
International Journal of Cancer|December 2, 1993
Tamoxifen modulation of cisplatin cytotoxicity in human malignanciesE F McClay, K D Albright, J A Jones, et al.
Cancer Research|July 1, 1997
Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sitesJ A Jones, K D Albright, R D Christen, et al.
British Journal of Cancer|June 1, 2001
Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cellsA Nehmé, P Varadarajan, G Sellakumar, et al.
The Journal of Clinical Investigation|July 1, 1993
In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesR D Christen, A P Jekunen, J A Jones, et al.
British Journal of Cancer|March 31, 1999
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cellsA Nehmé, R Baskaran, S Nebel, et al.
British Journal of Cancer|January 1, 1997
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissuesD Fink, S Nebel, S Aebi, et al.
Cancer Research|September 1, 1996
Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatinE F McClay, J A Jones, P J Winski, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cancer Research|March 14, 2001
P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatinX Lin, K Ramamurthi, M Mishima, et al.
Cancer Research|April 1, 1993
Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cellsE F McClay, K D Albright, J A Jones, et al.
British Journal of Cancer|September 1, 1994
Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell linesE F McClay, K D Albright, J A Jones, et al.
International Journal of Cancer|December 2, 1993
Tamoxifen modulation of cisplatin cytotoxicity in human malignanciesE F McClay, K D Albright, J A Jones, et al.
Cancer Research|July 1, 1997
Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sitesJ A Jones, K D Albright, R D Christen, et al.
British Journal of Cancer|June 1, 2001
Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cellsA Nehmé, P Varadarajan, G Sellakumar, et al.
The Journal of Clinical Investigation|July 1, 1993
In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubulesR D Christen, A P Jekunen, J A Jones, et al.
British Journal of Cancer|March 31, 1999
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cellsA Nehmé, R Baskaran, S Nebel, et al.
British Journal of Cancer|January 1, 1997
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissuesD Fink, S Nebel, S Aebi, et al.
Cancer Research|September 1, 1996
Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatinE F McClay, J A Jones, P J Winski, et al.
Pageof 4